Results 171 to 180 of about 186,195 (263)

Donor-derived membranous nephropathy. [PDF]

Clin Kidney J
Chakraborty R, Sheaff M, Yaqoob MM.
europepmc   +1 more source

Effect of glucagon‐like peptide 1 receptor agonists on systolic blood pressure in patients with obesity, with or without diabetes: A systematic review and network meta‐analysis

Clinical Obesity, EarlyView.
Summary The effect of glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) on systolic blood pressure (SBP) in patients with obesity with or without diabetes remains unclear. The aim was to compare the effect of different drug–dose combinations of GLP‐1RAs on SBP.
Abraish Ali, Asad Ali Siddiqui, Muhammad Shariq Usman, Izza Shahid, Muhammad Shahzeb Khan, Prinka Perswani   +5 more
wiley   +1 more source

Case of class II lupus nephritis with nephrotic features in the context of belimumab: Intersecting clinical challenge with academic initiative to emphasize social barriers in care. [PDF]

SAGE Open Med Case Rep
Cho A, Shoemaker J, Matarneh A, Sardar S, Mohan P, Washburn E, Karasinski A, Kaur G, Ghahramani N.   +8 more
europepmc   +1 more source

Lactate and Lactylation in AKI‐to‐CKD: Epigenetic Regulation and Therapeutic Opportunities

Cell Proliferation, EarlyView.
ABSTRACT Lactate is not only a byproduct of glycolysis, but is also considered an energy source, gluconeogenic precursor, signalling molecule and protein modifier during the process of cellular metabolism. The discovery of lactylation reveals the multifaceted functions of lactate in cellular metabolism and opens new avenues for lactate‐related research.
Yi Hou, Dongwei Liu, Zuishuang Guo, Cien Wei, Fengyu Cao, Yue Xu, Qi Feng, Fengxun Liu   +7 more
wiley   +1 more source

Augmenting Primary Prevention of Sudden Cardiac Arrest in a Young Population. [PDF]

J Am Heart Assoc
Cho SMJ, Yoo TH.
europepmc   +1 more source

Pregnancy outcomes in women with young‐onset type 2 diabetes: the impact of age of diabetes diagnosis and duration of diabetes

Diabetic Medicine, EarlyView.
Abstract Aims Young‐onset type 2 diabetes mellitus (YT2DM) is an aggressive phenotype, with some claiming that diagnosis at <40 years of age represents a distinct higher risk group. Others have suggested restricting YT2DM to those diagnosed at <30 years of age.
Xi May Zhen, Glynis Ross, Amanda Gauld, Alberto Nettel‐Aguirre, Stephanie Noonan, Maria Constantino, Arianne Sweeting, Anna‐Jane Harding, Adam Mackie, Hend Chatila, Margaret McGill, Timothy Middleton, Ted Wu, Stephen Twigg, Jencia Wong   +14 more
wiley   +1 more source

Modern Biomarkers in IgA Nephropathy and Their Potential in Paediatric Research. [PDF]

J Clin Med
Such-Gruchot A, Mizerska-Wasiak M, Płatos E, Pańczyk-Tomaszewska M.   +3 more
europepmc   +1 more source

CAR‐T Cell Therapy in Autoimmune Setting: A New Appealing Approach Extendable to Allergy?

Allergy, EarlyView.
Federico Rossi, Rubén Fernandez Santamaria, Riccardo Castagnoli   +2 more
wiley   +1 more source

Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for clinicians

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Albuminuria, the abnormal presence of albumin in urine, is a key marker of kidney damage and a strong predictor of kidney and cardiovascular outcomes. Its clinical significance has evolved from early historical observations to its current role in chronic kidney disease (CKD) detection, risk stratification and treatment monitoring.
Jelle M. Beernink, Dominique van Mil, Gozewijn D. Laverman, Hiddo J. L. Heerspink, Ron T. Gansevoort   +4 more
wiley   +1 more source

Calycosin ameliorates albuminuria in nephrotic syndrome by targeting Notch1/Snail pathway. [PDF]

BMC Nephrol
Ma X, Guan B, Pang L.
europepmc   +1 more source